Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Destiny B. Sykes is active.

Publication


Featured researches published by Destiny B. Sykes.


Molecular Pharmacology | 2010

Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier

Xuequian Wang; Destiny B. Sykes; David Miller

ATP-driven efflux transporters at the blood-brain barrier both protect against neurotoxicants and limit drug delivery to the brain. In other barrier and excretory tissues, efflux transporter expression is regulated by certain ligand-activated nuclear receptors. Here we identified constitutive androstane receptor (CAR) as a positive regulator of P-glycoprotein, multidrug resistance-associated protein 2 (Mrp2), and breast cancer resistance protein (BCRP) expression in rat and mouse brain capillaries. Exposing rat brain capillaries to the CAR activator, phenobarbital (PB), increased the transport activity and protein expression (Western blots) of P-glycoprotein, Mrp2, and BCRP. Induction of transport was abolished by the protein phosphatase 2A inhibitor, OA. Similar effects on transporter activity and expression were found when mouse brain capillaries were exposed to the mouse-specific CAR ligand, 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP). In brain capillaries from CAR-null mice, TCPOBOP did not increase transporter activity. Finally, treating mice with 0.33 mg/kg TCPOBOP or rats with 80 mg/kg PB increased P-glycoprotein-, Mrp2-, and BCRP-mediated transport and protein expression in brain capillaries assayed ex vivo. Thus, CAR activation selectively tightens the blood-brain barrier by increasing transport activity and protein expression of three xenobiotic efflux pumps.


The Journal of Neuroscience | 2010

Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor.

Brian T. Hawkins; Destiny B. Sykes; David Miller

Increased brain expression of vascular endothelial growth factor (VEGF) is associated with neurological disease, brain injury, and blood–brain barrier (BBB) dysfunction. However, the specific effect of VEGF on the efflux transporter P-glycoprotein, a critical component of the BBB, is not known. Using isolated rat brain capillaries and in situ rat brain perfusion, we determined the effect of VEGF exposure on P-glycoprotein activity in vitro and in vivo. In isolated capillaries, VEGF acutely and reversibly decreased P-glycoprotein transport activity without decreasing transporter protein expression or opening tight junctions. This effect was blocked by inhibitors of the VEGF receptor flk-1 and Src kinase, but not by inhibitors of phosphatidylinositol-3-kinase or protein kinase C. VEGF also increased Tyr-14 phosphorylation of caveolin-1, and this was blocked by the Src inhibitor PP2. Pharmacological activation of Src kinase activity mimicked the effects of VEGF on P-glycoprotein activity and Tyr-14 phosphorylation of caveolin-1. In vivo, intracerebroventricular injection of VEGF increased brain distribution of P-glycoprotein substrates morphine and verapamil, but not the tight junction marker, sucrose; this effect was blocked by PP2. These findings indicate that VEGF decreases P-glycoprotein activity via activation of flk-1 and Src, and suggest Src-mediated phosphorylation of caveolin-1 may play a role in downregulation of P-glycoprotein activity. These findings also imply that P-glycoprotein activity is acutely diminished in pathological conditions associated with increased brain VEGF expression and that BBB VEGF/Src signaling could be targeted to acutely modulate P-glycoprotein activity and thus improve brain drug delivery.


Biochimica et Biophysica Acta | 1999

Multiple effects of mercuric chloride on hexose transport in Xenopus oocytes.

David M Barnes; Destiny B. Sykes; David S. Miller

HgCl(2) had both stimulatory and inhibitory effects on [(3)H]2-deoxyglucose (DG) uptake in Xenopus laevis oocytes. The Hg dose response was complex, with 0.1-10 microM Hg increasing total DG uptake, 30-50 microM Hg inhibiting, and concentrations >100 microM increasing uptake. Analyses of the effects of Hg on DG transport kinetics and cell membrane permeability indicated that low concentrations of Hg stimulated mediated uptake, intermediate concentrations inhibited mediated uptake, but high Hg concentrations increased non-mediated uptake. 10 microM Hg increased the apparent V(max) for DG uptake, but caused little or no change in apparent K(m). Phenylarsine oxide prevented the increase in DG uptake by 10 microM Hg, suggesting that the increase was due to transporter recruitment. Microinjecting low doses of HgCl(2) into the cell increased mediated DG uptake. Higher intracellular doses of Hg increased both mediated and non-mediated DG uptake. Both insulin and Hg cause cell swelling in isotonic media and, for insulin, this swelling has been linked to the mechanism of hormone action. Osmotically swelling Xenopus oocytes stimulated DG transport 2-5-fold and this increase was due to an increased apparent V(max). Exposing cells to 10 microM Hg or 140 nM insulin both increased cellular water content by 18% and increased hexose transport 2-4-fold. These data indicate that low concentrations of Hg and insulin affect hexose transport in a similar manner and that for both an increase cellular water content could be an early event in signaling the increase in hexose transport.


Journal of Toxicology and Environmental Health | 2002

Mercuric chloride acting through Mg stimulates protein synthesis in Xenopus oocytes.

David M. Barnes; Destiny B. Sykes; David S. Miller

In Xenopus laevis oocytes, addition of HgCl (Hg) to the medium rapidly stimulated 2 incorporation of [ 35 S]methionine (MET) into protein, increasing incorporation up to fivefold over control values. The action of inorganic mercury persisted after removal of Hg. Microinjection of HgCl 2 into oocytes maintained in buffer also increased MET incorporation. However, no such stimulation was found when Hg was microinjected into oocytes maintained under oil, suggesting that Hg action was dependent on a cell-medium interaction. Removing medium Mg 2+ decreased insulin- and Hg-stimulated methionine incorporation. Increasing medium Mg 2+ from 1 m M to 10 m M increased Hg-stimulated methionine incorporation twofold. Hypotonic swelling of oocytes stimulated hexose transport but inhibited protein synthesis. Together these data indicate that inorganic mercury activates translation in the oocyte through an Mg-dependent mechanism, possibly increased Mg 2+ influx.


American Journal of Physiology-renal Physiology | 2004

Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice.

Destiny B. Sykes; Douglas H. Sweet; Simon Lowes; Sanjay K. Nigam; John B. Pritchard; David S. Miller


American Journal of Physiology-renal Physiology | 2002

Confocal imaging of organic anion transport in intact rat choroid plexus

Christopher M. Breen; Destiny B. Sykes; Gert Fricker; David S. Miller


American Journal of Physiology-renal Physiology | 1994

ATP-dependent transport of tetraethylammonium by endosomes isolated from rat renal cortex

John B. Pritchard; Destiny B. Sykes; David Miller


American Journal of Physiology-renal Physiology | 2004

Fluorescein-methotrexate transport in rat choroid plexus analyzed using confocal microscopy

Christopher M. Breen; Destiny B. Sykes; Carsten H. Baehr; Gert Fricker; David Miller


Journal of Cellular Physiology | 1995

Multiple sites of vanadate and peroxovanadate action in Xenopus oocytes.

David M. Barnes; Destiny B. Sykes; Yoram Shechter; David S. Miller


Journal of Cellular Physiology | 1991

Stimulation of protein synthesis by internalized insulin.

David S. Miller; Destiny B. Sykes

Collaboration


Dive into the Destiny B. Sykes's collaboration.

Top Co-Authors

Avatar

David S. Miller

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christopher M. Breen

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

David M. Barnes

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amy G. Aslamkhan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge